Interestingly, mice treated with either semaglutide or dapagliflozin display intermediate values for these markers, suggesting a potential impact of these treatments on metabolic parameters
Expired or compromised semaglutide should be disposed of properly
Patients start on a very low dose just .25 mg each week for the first month, administered via epi-pen injection
For example, Rybelsus (semaglutide tablets), the first oral GLP-1 approved for type 2 diabetes, has demonstrated meaningful weight loss in clinical studies, although it currently requires strict administration guidelines (empty stomach, limited fluid intake before and after dosing)
One study found that Wegovy 2.4 mg led to an average weight loss of ~14% of body weight after 40 weeks of treatment
Clinically meaningful response usually begins at 1.0 mg or higher